Vaccine Pharmacovigilance: Safety in numbers

Presented by Sarah Hall, Mipsol Limited


Event Webinar
Type Virtual Event
Language English
Date(s) 12 Apr. 2022
Day(s) 17:00 - 18:00
Duration 1 Hour

This webinar will discuss vaccine-specific pharmacovigilance requirements in Europe during clinical development and post-authorisation. The ongoing safety assessment of the COVID vaccines will be discussed.

Vaccine Pharmacovigilance: Safety in numbers If you have any Questions about Vaccine pharmacovigilance, please submit your questions using the following link: Click Here


17:00 Opening of the Webinar
17:00 Welcome and Introduction
17:05 Vaccine pharmacovigilance requirements and differences from ‘standard’ pharmacovigilance
Sarah Hall, Mipsol Limited
17:40 Q&A Session
Moderator(s): Seif Eddine Amara Madi, GSK
Sarah Hall, Mipsol Limited
18:00 End of the Webinar